Gene: TMEM68
Official Full Name: transmembrane protein 68provided by HGNC
Gene Summary: Enables phospholipid:diacylglycerol acyltransferase activity. Involved in triglyceride biosynthetic process. Is active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05359 | TMEM68 Knockout cell line (HeLa) | Human | TMEM68 | 1:3~1:6 | Negative | Online Inquiry |
KO05360 | TMEM68 Knockout cell line (HCT 116) | Human | TMEM68 | 1:2~1:4 | Negative | Online Inquiry |
KO05361 | TMEM68 Knockout cell line (HEK293) | Human | TMEM68 | 1:3~1:6 | Negative | Online Inquiry |
KO05362 | TMEM68 Knockout cell line (A549) | Human | TMEM68 | 1:3~1:4 | Negative | Online Inquiry |
TMEM68 Gene Knockout Cell Lines are specialized cellular models designed to investigate the function and biological roles of the transmembrane protein 68 (TMEM68). This gene has emerged as a significant contributor to various physiological processes, including cellular signaling, metabolic regulation, and organelle homeostasis. The knockout cell lines are engineered through advanced gene editing techniques, such as CRISPR-Cas9, which facilitate the specific disruption of the TMEM68 gene, allowing researchers to observe the resulting phenotypic and molecular changes.
The primary mechanism by which TMEM68 influences cellular function is through its involvement in the transport and turnover of intracellular components, making it essential for maintaining cellular integrity and response to stressors. By utilizing these knockout cell lines, scientists can elucidate the role of TMEM68 in critical biological pathways, providing insights that may lead to novel therapeutic targets, especially in metabolic disorders and cancers where cell signaling and metabolism are dysregulated.
This product holds significant scientific importance as it enables researchers to conduct targeted studies that compare wild-type and TMEM68-deficient cells, thus offering a powerful tool for dissecting the molecular underpinnings of various diseases. Additionally, these cell lines present a unique advantage over traditional models by providing specific and consistent genetic alterations, which facilitate reproducibility and reliability in experimental outcomes.
Researchers and clinicians seeking to explore the multifaceted role of TMEM68 in cellular physiology will find tremendous value in the TMEM68 Gene Knockout Cell Lines. The ability to directly manipulate this gene opens diverse avenues for therapeutic research and development, enhancing understanding of disease mechanisms.
Our company prides itself on its commitment to providing high-quality biological products, with an expertise that spans gene editing technologies and cellular biology. We strive to empower the research community with innovative models that can drive forward scientific discovery and translate into real-world applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.